Form 4: Ekso Bionics Holdings CEO Receives Stock Grant
Insider Transaction (Form 4)
Ying Cenly Chen, Chief Executive Officer and a Director of Ekso Bionics Holdings, Inc., received 2,800,000 shares of common stock on July 13, 2026.
Summary
- Grant/award: acquired 2,800,000 Common Stock on July 13, 2026; holds 2,800,000 after (Direct).
Sentiment
Score: 5
Explanation: StockSavvy.ai views this as routine: the reported changes are grants, option exercises, tax withholding or similar administrative transactions, which carry limited directional signal.
Insider Transactions
Ying Cenly Chen — Director, Officer (Chief Executive Officer)
| Date | Transaction | Security | Shares | Price | Value | Held After |
|---|---|---|---|---|---|---|
| 2026-07-13 | Grant/award | Common Stock | 2,800,000 | — | — | 2,800,000 |
Key Dates
| Date | Description |
|---|---|
| 2026-07-13 | Grant/award (2,800,000 shares) |
Keywords
insider transaction, Form 4, CHRN, ChronoScale Holdings Corp, neutral, Ying Cenly Chen
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.